-
DCcov: Repositioning of Drugs and Drug Combinations for SARS-CoV-2 Infected Lung through Constraint-Based Modelling
Authors:
Ali Kishk,
Maria Pires Pacheco,
Thomas Sauter
Abstract:
The 2019 coronavirus disease (COVID-19) became a worldwide pandemic with currently no effective antiviral drug except treatments for symptomatic therapy. Flux balance analysis is an efficient method to analyze metabolic networks. It allows optimizing for a metabolic function and thus e.g., predicting the growth rate of a specific cell or the production rate of a metabolite of interest. Here flux b…
▽ More
The 2019 coronavirus disease (COVID-19) became a worldwide pandemic with currently no effective antiviral drug except treatments for symptomatic therapy. Flux balance analysis is an efficient method to analyze metabolic networks. It allows optimizing for a metabolic function and thus e.g., predicting the growth rate of a specific cell or the production rate of a metabolite of interest. Here flux balance analysis was applied on human lung cells infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to reposition metabolic drugs and drug combinations against the replication of the SARS-CoV-2 virus within the host tissue. Making use of expression data sets of infected lung tissue, genome-scale COVID-19-specific metabolic models were reconstructed. Then host-specific essential genes and gene-pairs were determined through in-silico knockouts that permit reducing the viral biomass production without affecting the host biomass. Key pathways that are associated with COVID-19 severity in lung tissue are related to oxidative stress, as well as ferroptosis, sphingolipid metabolism, cysteine metabolism, and fat digestion. By in-silico screening of FDA approved drugs on the putative disease-specific essential genes and gene-pairs, 45 drugs and 99 drug combinations were predicted as promising candidates for COVID-19 focused drug repositioning (https://github.com/sysbiolux/DCcov). Among the 45 drug candidates, six antiviral drugs were found and seven drugs that are being tested in clinical trials against COVID-19. Other drugs like gemcitabine, rosuvastatin and acetylcysteine, and drug combinations like azathioprine-pemetrexed might offer new chances for treating COVID-19.
△ Less
Submitted 25 March, 2021;
originally announced March 2021.
-
Fast reconstruction of compact context-specific metabolic networks via integration of microarray data
Authors:
Maria Pires Pacheco,
Thomas Sauter
Abstract:
Recently we proposed an algorithm for the fast reconstruction of compact context-specific metabolic networks (FASTCORE) that allowed dropping the reconstruction time to the time order of seconds (Vlassis et al.,2014). This extremely low computational demand opens new possibilities for improving the quality of the models. Several rounds of model reconstruction, testing of the model's predictions ag…
▽ More
Recently we proposed an algorithm for the fast reconstruction of compact context-specific metabolic networks (FASTCORE) that allowed dropping the reconstruction time to the time order of seconds (Vlassis et al.,2014). This extremely low computational demand opens new possibilities for improving the quality of the models. Several rounds of model reconstruction, testing of the model's predictions against real experimental data, curation steps of the input model and the set of core reactions as well as cross-validations assays are required to reconstruct high-quality models. These semi-automated model curations steps are in such extend not possible with competing algorithms due to their high computational demands. To adapt FASTCORE for the integration of microarray data, we therefore propose a new workflow: FASTCORMICS. FASTCORMICS requires as input microarray data and a Genome-scale reconstruction. FASTCORMICS is devoid of heuristic parameter settings and has a low computational demand with overall building times in the order of a few minutes. FASTCORMICS preprocesses the microarrays data with the discretization tool Barcode (Zillox et al, 2007). Barcode uses prior knowledge on the intensity distribution of each probe set for a given microarray platform to segregate between expressed genes and non-expressed genes. This preprocessing step allows circumventing the need of setting a heuristic expression threshold, which is critical for the output models as in response to this threshold alternative pathways or subsystems might be included or excluded, thereby heavily changing the functionalities of the model.
In general, FASTCORMICS outperforms competing algorithms and allows obtaining high-quality, robust models in a high-throughput manner. This will allow the use of metabolic modelling as routine process for the analysis of microarray data e.g. in the field of personalized medicine.
△ Less
Submitted 24 July, 2014;
originally announced July 2014.
-
Fast Reconstruction of Compact Context-Specific Metabolic Network Models
Authors:
Nikos Vlassis,
Maria Pires Pacheco,
Thomas Sauter
Abstract:
Systemic approaches to the study of a biological cell or tissue rely increasingly on the use of context-specific metabolic network models. The reconstruction of such a model from high-throughput data can routinely involve large numbers of tests under different conditions and extensive parameter tuning, which calls for fast algorithms. We present FASTCORE, a generic algorithm for reconstructing con…
▽ More
Systemic approaches to the study of a biological cell or tissue rely increasingly on the use of context-specific metabolic network models. The reconstruction of such a model from high-throughput data can routinely involve large numbers of tests under different conditions and extensive parameter tuning, which calls for fast algorithms. We present FASTCORE, a generic algorithm for reconstructing context-specific metabolic network models from global genome-wide metabolic network models such as Recon X. FASTCORE takes as input a core set of reactions that are known to be active in the context of interest (e.g., cell or tissue), and it searches for a flux consistent subnetwork of the global network that contains all reactions from the core set and a minimal set of additional reactions. Our key observation is that a minimal consistent reconstruction can be defined via a set of sparse modes of the global network, and FASTCORE iteratively computes such a set via a series of linear programs. Experiments on liver data demonstrate speedups of several orders of magnitude, and significantly more compact reconstructions, over a chief rival method. Given its simplicity and its excellent performance, FASTCORE can form the backbone of many future metabolic network reconstruction algorithms.
△ Less
Submitted 23 November, 2013; v1 submitted 30 April, 2013;
originally announced April 2013.
